{"artifact_id":"analysis-SDA-2026-04-02-gap-v2-5d0e3052","artifact_type":"analysis","title":"How does metabolic reprogramming (glucose metabolism shifts, brain insulin resistance, ketone body utilization) affect neuronal survival in neurodegenerative diseases? What metabolic interventions (ketogenic diet, GLP-1 agonists, metformin) show therapeutic promise?","quality_score":0.3,"is_latest":1,"version_number":6,"version_count":1,"debate_count":0,"supports_count":0,"contradicts_count":0,"neutral_count":0,"incoming_by_type":{"derives_from":12,"related":406,"mentions":1972},"total_incoming":2390,"outgoing_by_type":{"derives_from":3,"related":2217,"produces":1,"analysis_target":1},"total_outgoing":2222,"quality_trajectory":[{"score":0.3,"at":"2026-05-16T14:51:34.657673-07:00"},{"score":0.3,"at":"2026-05-16T08:03:22.955306-07:00"},{"score":0.3,"at":"2026-04-28T20:23:42.629701-07:00"},{"score":0.3,"at":"2026-04-28T20:23:42.629701-07:00"},{"score":0.3,"at":"2026-04-28T03:48:49.857966-07:00"}],"evidence_balance":0.0,"evidence_certainty":1.0,"total_evidence_items":4612,"is_well_supported":false,"is_controversial":false,"is_foundational":true}